AMANDA SELF: Open Payments
NPI 1609276732 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 103 payments from 23 companies in 2025. Trend: 2023 $928 · 2024 $1,735 · 2025 $1,910
Food & beverage: $1,910
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $246 |
| PFIZER INC. | 12 | $240 |
| Novo Nordisk Inc | 14 | $180 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $126 |
| ABBVIE INC. | 6 | $123 |
| Exact Sciences Corporation | 5 | $102 |
| Amgen Inc. | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Astellas Pharma US Inc | 4 | $77 |
Products named: NURTEC ODT, TRINTELLIX, MOUNJARO, JARDIANCE, Wegovy, ZEPBOUND, AIRSUPRA, PREVNAR 20.
Industry payments across FL — which companies pay providers there.
